J. Bartlett

Infectious Diseases · Clinical Infectious Diseases · 2000–2013

A researcher in the Science corpus: 12 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 52 citations into it
• Critical Care and Intensive Care Medicine — 33 citations into it
• Gastroenterology — 5 citations into it

Whom J. Bartlett trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. L. Mcfarland
2. J. Pépin
3. Louis Valiquette

Who trusts J. Bartlett overall

1. Thierry Calandra

Papers from J. Bartlett's perspective

Ordered by how strongly the researchers J. Bartlett trusts endorse each paper. Same corpus, a different order for every researcher.

1. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. (New England Journal of Medicine)
2. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity (Canadian Medical Association Journal)
3. Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications (Annals of Surgery)
4. Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (Clinical Infectious Diseases)
5. A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use (Infection Control & Hospital Epidemiology)
6. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. (Clinical Infectious Diseases)
7. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (Journal of the American Medical Association (JAMA))
8. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. (New England Journal of Medicine)
9. Epidemiology of methicillin-resistant Staphylococcus aureus. (Clinical Infectious Diseases)
10. Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated Disease

Their papers

• The Future of Antibiotics and Resistance (2013) — 645 citations
• Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) — 1,708 citations
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009) — 4,597 citations
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007) — 6,366 citations
• Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease (2006) — 645 citations
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (2006) — 1,127 citations
• Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. (2005) — 762 citations
• Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. (2004) — 800 citations
• Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003) — 1,005 citations
• Botulinum toxin as a biological weapon: medical and public health management. (2001) — 1,721 citations
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (2000) — 2,173 citations
• Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. (2000) — 969 citations